Neena Bitritto-Garg

Stock Analyst at Deutsche Bank

(4.25)
# 851
Out of 4,495 analysts
76
Total ratings
47.06%
Success rate
19.08%
Average return

18 Stocks

Roivant Sciences
Apr 3, 2024
Maintains: Buy
Price Target: $14$15
Current: $11.61
Upside: +29.20%
Amylyx Pharmaceuticals
Mar 11, 2024
Maintains: Buy
Price Target: $36$8
Current: $2.36
Upside: +238.98%
ACADIA Pharmaceuticals
Dec 14, 2023
Downgrades: Hold
Price Target: $25
Current: $18.62
Upside: +34.26%
Immunovant
Dec 12, 2023
Initiates: Buy
Price Target: $50
Current: $30.92
Upside: +61.71%
Neurocrine Biosciences
Dec 12, 2023
Initiates: Buy
Price Target: $136
Current: $147.45
Upside: -7.77%
COMPASS Pathways
Dec 12, 2023
Initiates: Buy
Price Target: $16
Current: $7.67
Upside: +108.60%
Prothena Corporation
Dec 12, 2023
Initiates: Buy
Price Target: $62
Current: $24.13
Upside: +156.94%
Alector
Dec 12, 2023
Initiates: Buy
Price Target: $12
Current: $6.08
Upside: +97.37%
Sage Therapeutics
Dec 12, 2023
Initiates: Hold
Price Target: $21
Current: $12.16
Upside: +72.70%
Sarepta Therapeutics
Dec 12, 2023
Initiates: Buy
Price Target: $109
Current: $148.98
Upside: -26.84%
Acumen Pharmaceuticals
Dec 12, 2023
Initiates: Buy
Price Target: $8
Current: $3.15
Upside: +153.97%
Longboard Pharmaceuticals
Mar 9, 2023
Maintains: Buy
Price Target: $24$17
Current: $39.50
Upside: -56.96%
Atai Life Sciences
Jan 9, 2023
Maintains: Buy
Price Target: $20$10
Current: $1.64
Upside: +509.76%
Passage Bio
Nov 11, 2022
Maintains: Buy
Price Target: $7$5
Current: $0.95
Upside: +425.71%
Kodiak Sciences
Aug 2, 2022
Downgrades: Sell
Price Target: $6
Current: $3.24
Upside: +85.19%
Alpha Tau Medical
Apr 4, 2022
Initiates: Buy
Price Target: $21
Current: $2.09
Upside: +904.78%
Insmed
Jul 11, 2017
Initiates: Outperform
Price Target: n/a
Current: $77.98
Upside: -
AnaptysBio
Jul 11, 2017
Initiates: Outperform
Price Target: n/a
Current: $34.48
Upside: -